Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Lefrock

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Drug Intelligence & Clinical Pharmacy|June 1, 1985
Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitorB R Smith, J L LeFrock
American Family Physician|December 1, 1985
Health advice for the international travelerS J Weber, J L Lefrock
Antimicrobial Agents and Chemotherapy|July 1, 1985
Comparative in vitro evaluation of cefpimizole (U-63196E), a new antipseudomonal cephalosporinJ L LeFrock, B R Smith, J Bihl
The American Journal of the Medical Sciences|May 1, 1979
The impact of hospitalization on the aerobic fecal microfloraJ L LeFrock, C A Ellis, L Weinstein
Bulletin of the New York Academy of Medicine|May 1, 1984
The nonprophylactic role of cephalosporins in surgeryJ L LeFrock, A Molavi, B R Smith
The American Journal of the Medical Sciences|May 1, 1979
The relation between aerobic fecal and oropharyngeal microflora in hospitalized patientsJ L LeFrock, C A Ellis, L Weinstein
The Medical Clinics of North America|January 1, 1982
ClindamycinJ L LeFrock, A Molavi, R A Prince
The Medical Clinics of North America|January 1, 1982
MetronidazoleA Molavi, J L LeFrock, R A Prince
Bulletin of the New York Academy of Medicine|May 1, 1984
The nonprophylactic role of cephalosporins in obstetrics and gynecologyJ L LeFrock, B R Smith, A Molavi
American Family Physician|July 1, 1984
Drug therapy for bacterial osteomyelitisJ L Lefrock, B R Smith, A Molavi
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Drug Intelligence & Clinical Pharmacy|June 1, 1985
Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitorB R Smith, J L LeFrock
American Family Physician|December 1, 1985
Health advice for the international travelerS J Weber, J L Lefrock
Antimicrobial Agents and Chemotherapy|July 1, 1985
Comparative in vitro evaluation of cefpimizole (U-63196E), a new antipseudomonal cephalosporinJ L LeFrock, B R Smith, J Bihl
The American Journal of the Medical Sciences|May 1, 1979
The impact of hospitalization on the aerobic fecal microfloraJ L LeFrock, C A Ellis, L Weinstein
Bulletin of the New York Academy of Medicine|May 1, 1984
The nonprophylactic role of cephalosporins in surgeryJ L LeFrock, A Molavi, B R Smith
The American Journal of the Medical Sciences|May 1, 1979
The relation between aerobic fecal and oropharyngeal microflora in hospitalized patientsJ L LeFrock, C A Ellis, L Weinstein
The Medical Clinics of North America|January 1, 1982
ClindamycinJ L LeFrock, A Molavi, R A Prince
The Medical Clinics of North America|January 1, 1982
MetronidazoleA Molavi, J L LeFrock, R A Prince
Bulletin of the New York Academy of Medicine|May 1, 1984
The nonprophylactic role of cephalosporins in obstetrics and gynecologyJ L LeFrock, B R Smith, A Molavi
American Family Physician|July 1, 1984
Drug therapy for bacterial osteomyelitisJ L Lefrock, B R Smith, A Molavi
Pageof 11